Open menu
Alexey Kuroedov
Role of protein kinase C[beta] inhibitors and glycogen synthase kinase-3 inhibitors, new anti-diabetic drugs, in preventing atherogenic transformation of monocytes and endothelial activation
![Role of protein kinase C[beta] inhibitors and glycogen synthase kinase-3 inhibitors, new anti-diabetic drugs, in preventing atherogenic transformation of monocytes and endothelial activation](https://s3.amazonaws.com/readfeedstatic/book_covers/thumbnails/rf-placeholder.png)